Socio-economic analysis of cardiac resynchronization therapy

Journal of Interventional Cardiac Electrophysiology

Volumn 17, Issue 3, 2006, Pages 225-236

  Field, Michael E ^a   Sweeney, Michael O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiac arrest; Heart failure; Mortality

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DATA ANALYSIS; DEFIBRILLATOR; DISEASE SEVERITY; HEALTH CARE COST; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HUMAN; LIFE EXPECTANCY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SOCIOECONOMICS; SUDDEN DEATH; TREATMENT CONTRAINDICATION;

CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION MAKING; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE;

EID: 34247262669     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9079-4     Document Type: Review

References (80)

1. Schocken, D. D., Arrieta, M. I., leaverton, P. E., & Ross, E.A. (1992). Prevalence and mortality of congestive heart failure in the United States. Journal of the American College of Cardiology, 20, 301-306.
2. Ho, K. K. L., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. (1993) Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation, 88, 107-115.
3. Massie, B. M., & Shah, N. B. (1997). Evolving trends in the epidemiologic factors of heart failure. American Heart Journal, 133, 703-712.
4. Kannel, W. B., Plehn, J. F., & Cupples, A. (1988). Cardiac failure and sudden death in the Framingham Study. American Heart Journal, 115, 869-875.
5. SOLVD Investigators (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine, 327, 685-691.
6. Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Hartson, W. E., Tristani, F. E., et al. (1986). Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a veterans administration cooperative study. New England Journal of Medicine, 314, 1547-1552.
7. Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., et al. (1991). A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New England Journal of Medicine, 325, 303-310.
8. Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., et al. (1995). Amiodarone among patients with congestive heart failure and asymptomatic ventricular arrhythmias. New England Journal of Medicine, 333, 77-82.
9. Teerlink, J. R., Jalaluddin, M., Anderson, S., Kukin, M. L., Eichhorn, E. J., Francis, G., et al. (2000). Ambulatory ventricular arrhythmias among patients with heart failure do not specifically predict an increased risk of sudden death. Circulation, 101, 40-46.
10. American Heart Association (2003). Heart disease and stroke statistics-2003 update.
11. MERIT-HF Study Group (1999). Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet, 353, 2001-2007.
12. Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., et al. (1996). The effect of carvedilol on morbidity and mortality among patients with chronic heart failure. New England Journal of Medicine, 334, 1349-1355.
13. CIBIS II Investigators (1999). The cardiac insufficiency bisoprolol study II: A randomized trial. Lancet, 353, 9-13.
14. Moss, A. J. (1993). Sudden cardiac death and national health. Pacing and Clinical Electrophysiology, 16, 2190-2191.
15. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576-1583.
16. Kuck, K. H., Cappato, R., Siebels, J., Ruppel, F., for the CASH Investigators (2000). Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation, 102, 748-754.
17. Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., et al. (2000). Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 101, 1297-1302.
18. Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New England Journal of Medicine, 335, 1933-1940.
19. Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., Hafley, G. et al. (1999). A randomized study of the prevention of sudden death among patients with coronary artery disease. New England Journal of Medicine, 341, 1882-1890.
20. Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877-883.
21. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225-237.
22. Vassalo, J. A., Cassidy, D. M., Miller, J. M., Buxton, A. E., Marchlinski, F. E., et aL. (1986). Left ventricular endocardial activation during right ventricular pacing: Effect of underlying heart disease. Journal of the American College of Cardiology, 7, 1228-1233.
23. Prinzen, F. W., & Peschar, M. (2002). Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing and Clinical Electrophysiology, 25, 484-498.
24. Prinzen, F. W., Augustijn, C. H., Arts, T., Allessi, M. A., & Reneman, R. S. (1990). Redistribution of myocardial fiber strain and blood flow by asynchronous activation. American Journal of Physiology, H300-H308.
25. Thambo, J.-.B, Bordachar, P., Garrigue, S., Lafitte, S., Sanders, P., Reuter, S., et al. (2004). Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation, 110, 3766-3772.
26. Kanzaki, H., Bazaz, R., Schwartzman, D., Dohi, K., Sade, L. E., Gorscan, J. 3rd (2004). A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: Insights from mechanical activation strain mapping. Journal of the American College of Cardiology, 44, 1619-1625.
27. Maurer, G., Torres, M. A. R., Corday, E., Haendchen, R. V., & Meerbaum, S. (1984). Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: Relation to altered regional left ventricular function. Journal of the American College of Cardiology, 3, 986-991.
28. Vanderheyden, M., Goethals, M., Anguera, I., Nellens, P., Andries, E., Brugada, J., et al. (1997). Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system. Pacing and Clinical Electrophysiology, 20, 2422-2428.
29. Nielsen, J. C., Kristensen, L., Andersen, H. R., Mortensen, P. T., Pedersen, O., Pedersen, A. K. (2003). A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. Journal of the American College of Cardiology, 42, 614-623.
30. Nielsen, J. C., Andersen, H. R., Thomsen, P. E. B., Thuesen, L., Mortensen, P. T., Vesterlund, T., et al. (1998). Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation, 97, 987-995.
31. Nahlawi, M., Waligora, M., Spies, S. M., Bonow, R. O., Kadish, A. H., & Goldberger, J. (2004). Left ventricular function during and after right ventricular pacing. Journal of the American College of Cardiology, 44, 1883-1888.
32. Sweeney, M. O., Hellkamp, A. S., Ellenbogen, K. A., Greenspon, A. J., Freedman, R. A., Lee, K. L., et al. (2003). Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation, 23, 2932-2937.
33. Steinberg, J. S., Fischer, A., Wang, P., Schuger, C., Daubert, J., McNitt, S., et al. (2005). The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II. Journal of Cardiovascular Electrophysiology, 16, 359-365.
34. The DAVID Trial Investigators (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288, 3115-3123.
35. Shamim, W., Francis, D. P., Yousufuddin, M., Varney, S., Pieopli, M. F., Anker, S. D., et al. (1999). Intra-ventricular conduction delay: A prognostic marker in congestive heart failure. International Journal of Cardiology,70, 171-178.
36. Gerber, T. C., Nishimura, R., Holmes, D. R., Lloyd, M. A., Zehr, K. J., Tajik, A. Z., et al. (2001). Left ventricular and biventricular pacing in congestive heart failure. Mayo Clinic Proceedings, 706, 803-812.
37. Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., et al. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845-1853.
38. Cazeau, S., Leclerlq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New England Journal of Medicine, 344, 873-880.
39. Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J., Bakker, P., et al. (2002). Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Journal of the American College of Cardiology, 39, 2026-2033.
40. Cleland, J. G. F., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539-1549.
41. Bradley, D. J., Bradley, E. A., Baughman, K. L., Berger, R. D., Calkins, H., & Goodman, S. N. (2003). Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA, 289, 730-740.
42. Higgins, S. L., Hummel, J. D., Niazi, I. K., Giudici, M. C., Worley, S. J., Saxon, L. A., et al. (2003). Cardiac resynchronization therapy for the treatment of heart failure and intraventricular conduction delay and malignant ventricular tachyarrhythmia. Journal of the American College of Cardiology, 42, 1454-1459.
43. Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA, 289, 2685-2694.
44. Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140-2150.
45. Daubert, J. C., Leclercq, C., & Mabo, P. (2005). There is plenty of room for cardiac resynchronization therapy devices without backup defibrillators in the electrical treatment of heart failure. Journal of the American College of Cardiology, 46, 2204-2207.
46. Ellenbogen, K. A., Wood, M. A., & Klein, H. U. (2005). Why should we care about CARE-HF? Journal of the American College of Cardiology, 46, 2199-2203.
47. Hlatky, M. A. (2005) Cost effectiveness of cardiac resynchronization therapy. Journal of the American College of Cardiology, 46, 2322-2324.
48. Pratt, C. M., Greenway, P. A., Schoenfeld, M. L., Hibben, M. L., & Reiffel, J. A. (1996). Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials. Circulation, 93, 519-524.
49. Ypenburg, C., van Erven, L., Bleeker, G. B., Bax, J. J., Bootsma, M., Wijffels, M. C., et al. (2006). Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. Journal of the American College of Cardiology, 48, 464-470.
50. Ellenbogen, K. A., Levine, J. H., Berger, R. D., Daubert, J. P., Winters, S. L., Greenstein, E., et al. (2006). Are implantable cardioverter- defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation, 113, 776-782.
51. Wathen, M. S., DeGroot, P. J., Sweeney, M. O., Stark, A. J., Otterness, M. F., Adkisson, W. O., et al. (2004). Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators. PainFREE Rx II Trial Results. Circulation, 110, 2592-2596.
52. Shukla, G., Chaudry, M., Orlov, M., Hoffmeister, P., & Haffajee, C. (2005). Potential proarrhythmic effect of biventricular pacing: Fact or myth? Heart Rhythm, 2, 951-956.
53. Guerra, J., Wu, J., Miller, J. M., & Groh, W. J. (2003). Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. Journal of Cardiovascular Electrophysiology, 14, 1245-124.
54. Fish, J. M., Di Diego, J. M., Nesterenko, V., & Antzelevitch, C. (2004). Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: Implications for biventricular pacing. Circulation, 109, 2136-2142.
55. Medina-Ravell, V. A., Lankipalli, R. S., Yan, G. X., Anzelevitch, C., Medina-Malpica, N. A., Droogan, C., et al. (2003). Effect of epicardial or biventricular pacing to prolong QTinterval and increase transmural dispersion of repolarization. Circulation, 107, 740-746.
56. Wilkoff, B., Hess, M., Young, J. D., & Abraham, W. T. (2004). Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. Journal of Cardiovascular Electrophysiology, 15, 1002-1009.
57. Bansch, D., Antz, M., Boczor, S., Volkmer, M., Tebbenjohanns, J., Seidl, K., et al. (2002). Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation, 105, 1453-1458.
58. Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H. I., Schuger, C. D., Beau, S. L., et al. (2003). Amiodarone vs. implantable defibrillator: Randomized trial in patients with nonischemic cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. Journal of the American College of Cardiology, 41, 1707-1712.
59. Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A. M., Anderson, K. P., et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New England Journal of Medicine, 351, 2151-2158.
60. Theuns, D. A. M. J., Klootwijk, P. J., Goedhart, D. M., & Jordaens, L. J. L. M. (2004). Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. Journal of the American College of Cardiology, 44, 2362-2367.
61. Disenhofer, I., Kolb, C., Ndrepepa, G., Schreieck, J., Karch, M., Schmieder, S., et al. (2001). Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. Journal of Cardiovascular Electrophysiology, 12, 134-142.
62. Kuhlkamp, V., Dornberger, V., Mewis, C., Suchalla, R., Bosch, R. F., Seipel, L. (1999). Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. Journal of Cardiovascular Electrophysiology, 10, 905-915.
63. Sweeney, M. O., Wathen, M. S., Volosin, K., Abdalla, I., DeGroot, P. J., Otterness, M. F., et al. (2005). Appropriate and inappropriate ventricular therapies, quality of life and mortality among primary and secondary prevention ICD patients: Results from PainFREE Rx II. Circulation, 111, 2898-2905.
64. Namerow, P. B., Firth, B. R., Heywood, G. M., Windle, J. R., Parides, M. K., for the CABG Patch Trial Investigators and Coordinators (1999). Quality of Life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing and Clinical Electrophysiology, 22, 1305-1313.
65. Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., et al. (2002). Quality of life in the antiarrhythmics versus implantable defibrillators trial. Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation, 105, 589-594.
66. Irvine, J., Dorian,P., Baker, B., O'Brien, B. J., Roberts, R., Gent, M. et al. (2002). Quality of life in the Canadian Implantable Defibrillator Study (CIDS). American Heart Journal, 144, 282-289.
67. Cleland, J. G. F., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D.,Kappenberger, L., et al. (2006). Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. European Heart Journal, 27, 1928-1932.
68. Mark, D. B., Nelson, C. L., Anstrom, K. J., Al-Khatib, S. M., Tsiatis, A. A., Cowper, P. A., et al. (2006). Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation, 114, 135-142.
69. Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M., et al. (2006). The cost effectiveness of implantable cardioverter- defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology, 47, 2310-2318.
70. Hauser, R. G. (2005). The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. Journal of the American College of Cardiology, 45, 2022-2025.
71. Calvert, M. J., Freemantle, N., Yao, G., Cleland, J. G. F., Billingham, L., Daubert, J. C., et al. (2005). Cost-effectiveness of cardiac resynchronization therapy: Results from the CARE-HF Trial. European Heart Journal, 26, 2681-2688.
72. Feldman, A. M., de Lissovoy, G., Bristow, M. R., Saxon, L. A., De Marco, T., Kass, D. A., et al. (2005). Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Journal of the American College of Cardiology, 46, 2311-2321.
73. Moss, A. J. (2000). Implantable cardioverter defibrillator therapy: The sickest patients benefit the most. Circulation, 101, 1638-1640.
74. Uretsky, B., & Sheahan, G. (1997). Primary prevention of sudden cardiac death in heart failure: Will the result be shocking? Journal of the American College of Cardiology, 30, 1589-1597.
75. Luu, M., Stevenson, W. G., Saxon, L. A., & Stevenson, L. W. (1989). Diverse mechanisms of unexpected cardiac arrest in heart failure. Circulation, 80, 1675-1680.
76. Mitchell, L. B., Pineda, E. A., Titus, J. L., Bartosch, P. M., & Benditt, D. G. (2002). Sudden death in patients with implantable cardioverter defibrillators: Importance of post-shock electro-mechanical dissociation. Journal of the American College of Cardiology, 39, 1323-1328.
77. Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., et al. (2004). Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation, 110, 3760-3765.
78. Goldenberg, I., Moss, A. J., Hall, W. J., McNitt, S., Zareba, W., Andrews, M. L., et al. (2006). Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation, 113, 2810-2817.
79. Grimm, W., Christ, M., Bach, J., Muller, H. H., Maisch, B. (2003). Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation, 108, 2883-2891.
80. Bentkover, J. D., Stewart, E. J., Ignaszewski, A., Lepage, S., Liu, P., & Cooper, J. (2003). New technologies and potential cost savings related to morbidity and mortality reduction in Class III/ IV heart failure patients in Canada. International Journal of Cardiology, 88, 33-41.